Insider Buying: Ondine Biomedical Inc. (LON:OBI) Insider Acquires 200,775 Shares of Stock

Ondine Biomedical Inc. (LON:OBI) insider Carolyn Cross bought 200,775 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was bought at an average price of GBX 12 ($0.15) per share, for a total transaction of £24,093 ($29,921.76).

Ondine Biomedical Trading Up 7.1 %

Shares of Ondine Biomedical stock opened at GBX 12.85 ($0.16) on Friday. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37. Ondine Biomedical Inc. has a twelve month low of GBX 4.50 ($0.06) and a twelve month high of GBX 13.30 ($0.17). The firm has a market capitalization of £35.63 million, a PE ratio of -428.33 and a beta of 0.10. The firm’s 50-day moving average price is GBX 9.08 and its 200 day moving average price is GBX 7.95.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.